Press ReleaseSK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in… CISION PRNewswireFebruary 25, 2025
Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication Axiad’s PKI-based authentication enables scalability and flexibility in large-scale enterprise environments, elevates… CISION PRNewswireFebruary 25, 2025
Press ReleaseKangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma HEFEI, China, Feb. 25, 2025 /PRNewswire/ — Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today… CISION PRNewswireFebruary 25, 2025
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China SHANGHAI, Feb. 25, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:… CISION PRNewswireFebruary 25, 2025
Press ReleaseRoboSense Achieves Milestone with Production and Delivery of Its 1 Millionth LiDAR SHENZHEN, China, Feb. 25, 2025 /PRNewswire/ — On February 21, RoboSense (2498.HK), an… CISION PRNewswireFebruary 25, 2025
Press ReleaseCedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho The company will be the first 100% Brazilian mining company to verticalize… CISION PRNewswireFebruary 25, 2025
Press ReleaseRiyadh Air and IBM to build AI-driven enterprise, to elevate guest and employee experiences Agreement will see Riyadh Air leverage IBM watsonx and IBM Consulting solutions to… CISION PRNewswireFebruary 25, 2025
Press ReleaseAltair Joins the Piedmont Aerospace Cluster Altair technology to fuel innovation and the future of aerospace TROY, Mich.,… CISION PRNewswireFebruary 25, 2025
